182
Participants
Start Date
July 31, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
HTU-520 Patch
Terbinafine hydrochloride patch
Placebo Patch
Treatment with Placebo Patch
University of Pittsburg Medical Center, Department of Dermatology, Pittsburgh
Society Hill Dermatology, Philadelphia
Callender center for Clinical Research, Glenn Dale
Coastal Podiatry Group, Virginia Beach
Radiant Research, Inc., Anderson
Radiant Research, Inc., Atlanta
Ameriderm Research, Ormond Beach
Leavitt Medical Associates ofFL, Ormond Beach
Ameriderm Research, Jacksonville
Lake Washington Foot & Ankle Center, Melbourne
Florida Academic Dermatology Center, Miami
Dermatology Research Institute, Coral Gables
Center for Clinical and Cosmetic Research, Aventura
Marta Rendon, MD, Skin Care Research, Inc., Boca Raton
Pab Clinical Research, Brandon
Radiant Research, Inc., Pinellas Park
Total Skin and Beauty Dermatology Center, Birmingham
Radiant Research, Inc., Birmingham
UAB Department of Dermatology, Birmingham
University of Alabama at Birmingham, Birmingham
Derm Research, LLC, Louisville
Radiant Research, Inc., Akron
Group Health Associates, Tri-Health, Cincinnati
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Silverton Skin Institute, Grand Blanc
Assoc Foot Clinic & Surgery Specialists, Flint
University of Minnesota, Minnesota Clinical Study Center, Fridley
Radiant Research, Inc., Chicago
Radiant Research, St Louis
William P Coleman III, MD, Metairie
Central Sooner Research, Norman
Radiant Research, Inc., Dallas
Radiant Research, Inc., San Antonio
Radiant Research, Inc., Denver
Clinical Research Advantage, Inc., Glendale
Radiant Research, Inc., Tucson
Diagnamics, Inc., Encinatas
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
INDUSTRY